Has Mark Naylor, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,021 in general payments to Mark Naylor, MD across 110 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mark Naylor, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mark Naylor, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mark Naylor, MD

MOHS-Micrographic Surgery · Fayetteville, ARNPI 1518916386

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 35.9% of the total. Reporting peaked in 2022 at $1,112 and has fallen 73.6% since, to $294 in 2025.

$3,021in general payments, 2019–2025

Across 110 payments — averaging $27.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Pfizer$482
E.r. Squibb & Sons, L.L.C.$265
Amgen$189
Johnson & Johnson$175
Sun Pharmaceutical Industries Inc.$164
plus $662 from 16 others

What the payments were for

Food & beverage$3,007100%
Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	34	$1,085
Pfizer	18	$482
E.r. Squibb & Sons, L.L.C.	6	$265
Amgen	9	$189
Johnson & Johnson	7	$175
Sun Pharmaceutical Industries Inc.	9	$164
LEO Pharma Inc.	4	$114
Merz North America, Inc.	1	$100
Lilly USA, LLC	4	$97
Sanofi	3	$74
Regeneron Healthcare Solutions, Inc.	2	$49
Boehringer Ingelheim	2	$44
Novartis	1	$27
Organogenesis Inc.	1	$23
Sandoz	1	$20
UCB, Inc.	1	$19
Organon	2	$18
Biofrontera Inc.	1	$18
Incyte Corporation	1	$17
Galderma Laboratories, L.p.	1	$14
Dermavant Sciences, Inc.	1	$14
Journey Medical Corporation	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Rinvoq$564
XEOMIN$100
Sotyktu$100

How this compares

Too few mohs-micrographic surgery providers in Arkansasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$139,636

Medicare patients

515

Services billed

2,692

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	13	$52,035
Clobetasol Propionate	82	$4,627
Tacrolimus	15	$2,223
Triamcinolone Acetonide	179	$1,463
Dutasteride	28	$1,008
Imiquimod	18	$455
Minoxidil	38	$356
Minocycline Hcl	11	$327
Ketoconazole	22	$321
Mupirocin	43	$271
Clotrimazole	13	$261
Doxycycline Hyclate	21	$250
Prednisone	20	$39

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Fayetteville

Scott DinehartLittle Rock$268K
Colton NielsonJonesboro$13K
Justin McLawhornLittle Rock$13K
Kattie AllenBentonville$6K
Courtney BookBentonville$5K
Michael OsleberLittle Rock$2K
Stephen MasonHot Springs$2K
Joseph PurnellLittle Rock$1K
Randall BreauLittle Rock$1K

See the full list for Arkansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →